NM_001478.5:c.514G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001478.5(B4GALNT1):​c.514G>C​(p.Gly172Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0192 in 1,609,128 control chromosomes in the GnomAD database, including 397 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G172S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.028 ( 84 hom., cov: 33)
Exomes 𝑓: 0.018 ( 313 hom. )

Consequence

B4GALNT1
NM_001478.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.526

Publications

11 publications found
Variant links:
Genes affected
B4GALNT1 (HGNC:4117): (beta-1,4-N-acetyl-galactosaminyltransferase 1) GM2 and GD2 gangliosides are sialic acid-containing glycosphingolipids. GalNAc-T is the enzyme involved in the biosynthesis of G(M2) and G(D2) glycosphingolipids. GalNAc-T catalyzes the transfer of GalNAc into G(M3) and G(D3) by a beta-1,4 linkage, resulting in the synthesis of G(M2) and G(D2), respectively. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2013]
B4GALNT1 Gene-Disease associations (from GenCC):
  • complex hereditary spastic paraplegia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 26
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021012425).
BP6
Variant 12-57630495-C-G is Benign according to our data. Variant chr12-57630495-C-G is described in ClinVar as Benign. ClinVar VariationId is 380791.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0279 (4244/152302) while in subpopulation AFR AF = 0.0485 (2014/41554). AF 95% confidence interval is 0.0467. There are 84 homozygotes in GnomAd4. There are 2156 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 84 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
B4GALNT1NM_001478.5 linkc.514G>C p.Gly172Arg missense_variant Exon 5 of 11 ENST00000341156.9 NP_001469.1 Q00973-1B4DSP5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
B4GALNT1ENST00000341156.9 linkc.514G>C p.Gly172Arg missense_variant Exon 5 of 11 1 NM_001478.5 ENSP00000341562.4 Q00973-1

Frequencies

GnomAD3 genomes
AF:
0.0279
AC:
4241
AN:
152184
Hom.:
83
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0485
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0122
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0180
Gnomad FIN
AF:
0.0503
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0189
Gnomad OTH
AF:
0.0215
GnomAD2 exomes
AF:
0.0191
AC:
4719
AN:
246592
AF XY:
0.0188
show subpopulations
Gnomad AFR exome
AF:
0.0461
Gnomad AMR exome
AF:
0.00637
Gnomad ASJ exome
AF:
0.0247
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0461
Gnomad NFE exome
AF:
0.0165
Gnomad OTH exome
AF:
0.0180
GnomAD4 exome
AF:
0.0183
AC:
26593
AN:
1456826
Hom.:
313
Cov.:
32
AF XY:
0.0182
AC XY:
13168
AN XY:
724394
show subpopulations
African (AFR)
AF:
0.0490
AC:
1630
AN:
33284
American (AMR)
AF:
0.00751
AC:
330
AN:
43966
Ashkenazi Jewish (ASJ)
AF:
0.0234
AC:
602
AN:
25746
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39660
South Asian (SAS)
AF:
0.0193
AC:
1651
AN:
85398
European-Finnish (FIN)
AF:
0.0445
AC:
2370
AN:
53234
Middle Eastern (MID)
AF:
0.0318
AC:
182
AN:
5718
European-Non Finnish (NFE)
AF:
0.0168
AC:
18651
AN:
1109626
Other (OTH)
AF:
0.0195
AC:
1172
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1401
2802
4204
5605
7006
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0279
AC:
4244
AN:
152302
Hom.:
84
Cov.:
33
AF XY:
0.0290
AC XY:
2156
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0485
AC:
2014
AN:
41554
American (AMR)
AF:
0.0121
AC:
186
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0245
AC:
85
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.0178
AC:
86
AN:
4824
European-Finnish (FIN)
AF:
0.0503
AC:
534
AN:
10608
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0189
AC:
1289
AN:
68024
Other (OTH)
AF:
0.0213
AC:
45
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
217
434
652
869
1086
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0170
Hom.:
23
Bravo
AF:
0.0253
TwinsUK
AF:
0.0143
AC:
53
ALSPAC
AF:
0.0132
AC:
51
ESP6500AA
AF:
0.0497
AC:
219
ESP6500EA
AF:
0.0180
AC:
155
ExAC
AF:
0.0198
AC:
2399
Asia WGS
AF:
0.0110
AC:
37
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spastic paraplegia Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
16
DANN
Benign
0.94
DEOGEN2
Benign
0.20
T;.;T;.;.;.
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.12
N
LIST_S2
Uncertain
0.86
D;D;D;.;D;D
MetaRNN
Benign
0.0021
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;.;.;L;L;.
PhyloP100
0.53
PrimateAI
Benign
0.40
T
PROVEAN
Benign
0.50
N;N;.;N;N;N
REVEL
Benign
0.12
Sift
Benign
0.12
T;T;.;T;T;T
Sift4G
Benign
0.58
T;T;T;T;T;.
Polyphen
0.0
B;.;P;.;.;.
Vest4
0.22
MPC
0.31
ClinPred
0.014
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.12
gMVP
0.66
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs810205; hg19: chr12-58024278; API